cilostazol has been researched along with Dementia in 5 studies
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of the present study was to investigate whether cilostazol use is associated with a lower risk of incident dementia in Asian patients with IHD, and whether these effects differed based on sex." | 7.88 | Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease. ( Jung, YS; Kim, MY; Lee, S; Noh, Y; Paik, HY; Shin, S; Son, SJ, 2018) |
| " We examined the potential association between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population." | 7.85 | Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study. ( Chang, YH; Chien, CY; Tai, SY; Yang, YH, 2017) |
| "In patients with mild dementia who had received donepezil and cilostazol (n = 34; 77." | 7.80 | Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study. ( Hattori, Y; Ihara, M; Kasahara, Y; Nishino, M; Okada, M; Saito, S; Taguchi, A; Takahashi, Y; Takata, Y; Tsuji, M; Yamamoto, Y, 2014) |
| "In this randomized clinical trial, cilostazol was well tolerated, although it did not prevent cognitive decline." | 5.69 | Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial. ( Aso, T; Fukushima, M; Fukuyama, H; Hattori, Y; Ihara, M; Kagimura, T; Kakuta, C; Kakuta, R; Kanki, R; Kawabata, N; Kitaguchi, H; Kojima, S; Kowa, H; Maki, T; Mizuno, T; Nagatsuka, K; Nakaoku, Y; Ohtani, R; Oishi, N; Oka, N; Saito, S; Shindo, A; Shindo, K; Sudoh, S; Suzuki, K; Tachibana, H; Taguchi, A; Takahashi, R; Takahashi, Y; Taketsuna, M; Tomimoto, H; Tonomura, S; Washida, K; Yamamoto, H; Yamamoto, K; Yamamoto, Y; Yasuno, F, 2023) |
| "The goal of the present study was to investigate whether cilostazol use is associated with a lower risk of incident dementia in Asian patients with IHD, and whether these effects differed based on sex." | 3.88 | Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease. ( Jung, YS; Kim, MY; Lee, S; Noh, Y; Paik, HY; Shin, S; Son, SJ, 2018) |
| " We examined the potential association between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population." | 3.85 | Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study. ( Chang, YH; Chien, CY; Tai, SY; Yang, YH, 2017) |
| "In patients with mild dementia who had received donepezil and cilostazol (n = 34; 77." | 3.80 | Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study. ( Hattori, Y; Ihara, M; Kasahara, Y; Nishino, M; Okada, M; Saito, S; Taguchi, A; Takahashi, Y; Takata, Y; Tsuji, M; Yamamoto, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, S | 2 |
| Suzuki, K | 1 |
| Ohtani, R | 1 |
| Maki, T | 1 |
| Kowa, H | 1 |
| Tachibana, H | 1 |
| Washida, K | 1 |
| Kawabata, N | 1 |
| Mizuno, T | 1 |
| Kanki, R | 1 |
| Sudoh, S | 1 |
| Kitaguchi, H | 1 |
| Shindo, K | 1 |
| Shindo, A | 1 |
| Oka, N | 1 |
| Yamamoto, K | 1 |
| Yasuno, F | 1 |
| Kakuta, C | 1 |
| Kakuta, R | 1 |
| Yamamoto, Y | 2 |
| Hattori, Y | 2 |
| Takahashi, Y | 2 |
| Nakaoku, Y | 1 |
| Tonomura, S | 1 |
| Oishi, N | 1 |
| Aso, T | 1 |
| Taguchi, A | 2 |
| Kagimura, T | 1 |
| Kojima, S | 1 |
| Taketsuna, M | 1 |
| Tomimoto, H | 1 |
| Takahashi, R | 1 |
| Fukuyama, H | 1 |
| Nagatsuka, K | 1 |
| Yamamoto, H | 1 |
| Fukushima, M | 1 |
| Ihara, M | 2 |
| Blair, GW | 1 |
| Appleton, JP | 1 |
| Law, ZK | 1 |
| Doubal, F | 1 |
| Flaherty, K | 1 |
| Dooley, R | 1 |
| Shuler, K | 1 |
| Richardson, C | 1 |
| Hamilton, I | 1 |
| Shi, Y | 1 |
| Stringer, M | 1 |
| Boyd, J | 1 |
| Thrippleton, MJ | 1 |
| Sprigg, N | 1 |
| Bath, PM | 1 |
| Wardlaw, JM | 1 |
| Kim, MY | 1 |
| Noh, Y | 1 |
| Son, SJ | 1 |
| Shin, S | 1 |
| Paik, HY | 1 |
| Lee, S | 1 |
| Jung, YS | 1 |
| Nishino, M | 1 |
| Tsuji, M | 1 |
| Kasahara, Y | 1 |
| Takata, Y | 1 |
| Okada, M | 1 |
| Tai, SY | 1 |
| Chien, CY | 1 |
| Chang, YH | 1 |
| Yang, YH | 1 |
2 trials available for cilostazol and Dementia
| Article | Year |
|---|---|
Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial.
Topics: Adult; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cilostazol; Cognitive Dysfunction; Dementia; | 2023 |
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mon
Topics: Age Factors; Cerebral Small Vessel Diseases; Cilostazol; Cognition Disorders; Dementia; Double-Blind | 2018 |
3 other studies available for cilostazol and Dementia
| Article | Year |
|---|---|
Effect of Cilostazol on Incident Dementia in Elderly Men and Women with Ischemic Heart Disease.
Topics: Aged; Aged, 80 and over; Cilostazol; Cohort Studies; Dementia; Female; Humans; Male; Myocardial Isch | 2018 |
Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
Topics: Aged; Cholinesterase Inhibitors; Cilostazol; Dementia; Donepezil; Drug Therapy, Combination; Female; | 2014 |
Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Cilostazol; Cohort Studies; Dementia; Fem | 2017 |